The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis
NCT02977117
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Endstage Renal Disease
Interventions
OTHER:
Dialysate magnesium (1.0 mmol/L)
OTHER:
Dialysate magnesium (0.5 mmol/L)
Sponsor
Iain Bressendorff